Eiger sanctioned: Celladon shareholders agree merger
Eiger Biopharmaceuticals has merged with what is left of gene therapy developer Celladon in a deal that will see the combined firm list on the NASDAQ.
Archives for March 25, 2016
Biogen ups biologics capacity 73% through extra 144,000L at new Swiss plant
Biogen will equip its new Swiss biomanufacturing plant with eight 18,000L stainless steel bioreactors supplied by ABEC.
GE calls on diagnostics systems firm LeukoDx for cell characterization tech
LeukoDx will develop a cell characterization system for GE Healthcare in a deal designed to bolster the latter’s cell therapy manufacturing technology offering.